REFERENCES
- Hwang SJ, Tsai JC, Chen HC. Epidemiology, impact and preventive care of chronic kidney disease in Taiwan. Nephrology. 2010;15(Suppl 2):3–9.
- Yavuz A, Tetta C, Ersoy FF, . Uremic toxins: A new focus on an old subject. Semin Dial. 2005;18:203–211.
- Ayodele OE, Alebiosu CO. Burden of chronic kidney disease: An international perspective. Adv Chronic Kidney Dis. 2010; 17:215–224.
- Murr R. Interplay between different epigenetic modifications and mechanisms. Adv Genet. 2010;70:101–141.
- van Vliet J, Oates NA, Whitelaw E. Epigenetic mechanisms in the context of complex diseases. Cell Mol Life Sci. 2007; 64:1531–1538.
- Calvanese V, Lara E, Kahn A, Fraga MF. The role of epigenetics in aging and age-related diseases. Aging Res Rev. 2009;8:268–276.
- Turek-Plewa J, Jagodziński PP. The role of mammalian DNA methyltransferases in the regulation of gene expression. Cell Mol Biol Lett. 2005;10:631–647.
- Fandy TE. Development of DNA methyltransferase inhibitors for the treatment of neoplastic diseases. Curr Med Chem. 2009;16:2075–2085.
- Pan Y, Sawalha AH. Epigenetic regulation and the pathogenesis of systemic lupus erythematosus. Transl Res. 2009;153:4–10.
- Ingrosso D, Cimmino A, Perna AF, . Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinemia in patients with uremia. Lancet. 2003;361:1693–1699.
- Ingrosso D, Perna AF. Epigenetics in hyperhomocysteinemic states. A special focus on uremia. Biochim Biophys Acta. 2009;1790:892–899.
- Castro R, Rivera I, Struys EA, . Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease. Clin Chem. 2003;49:1292–1296.
- Nanayakkara PW, Kiefte-de Jong JC, Stehouwer CD, . Association between global leukocyte DNA methylation, renal function, carotid intima-media thickness and plasma homocysteine in patients with stage 2–4 chronic kidney disease. Nephrol Dial Transplant. 2008;23:2586–2592.
- Stenvinkel P, Karimi M, Johansson S, . Impact of inflammation on epigenetic DNA methylation—a novel risk factor for cardiovascular disease? J Intern Med. 2007;261:488–499.
- Wu IW, Hsu KH, Lee CC, p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease. Nephrol Dial Transplant. 2011;26:938–947.
- Balada E, Ordi-Ros J, Serrano-Acedo S, Martinez-Lostao L, Rosa-Leyva M, Vilardell-Tarrés M. Transcript levels of DNA methyltransferases DNMT1, DNMT3A and DNMT3B in CD4+ T cells from patients with systemic lupus erythematosus. Immunology. 2008;124:339–347.
- Zhao M, Gao F, Wu X, Tang J, Lu Q. Abnormal DNA methylation in peripheral blood mononuclear cells from patients with vitiligo. Br J Dermatol. 2010;163:736–742.
- Hodge DR, Xiao W, Clausen PA, . Interleukin-6 regulation of the human DNA metyltransferase (HDNMT) gene in human erythroleukemia cells. J Biol Chem. 2001;276: 39508–39511.
- Montes de Oca A, Madueño JA, Martinez-Moreno JM, . High-phosphate-induced calcification is related to SM22α promoter methylation in vascular smooth muscle cells. J Bone Miner Res. 2010;25:1996–2005.
- Kaye M. The anemia associated with renal disease. J Lab Clin Med. 1958;52:83–100.
- Ting AH, Jair KW, Schuebel KE, Baylin SB. Differential requirement for DNA methyltransferase 1 in maintaining human cancer cell gene promoter hypermethylation. Cancer Res. 2006;66:729–735.